LEO Pharma
LEO Pharma A/S is a multinational Danish pharmaceutical company, founded in 1908, with a presence in about 100 countries. Its headquarters are in Ballerup, near Copenhagen The company is 100% integrated into a private foundation owned by the LEO Foundation. Leo Pharma develops and markets products for dermatology, bone remodeling thrombosis and coagulation. In 1945 it was the first producer of penicillin outside the US and UK.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Adbry | Tralokinumab | 2021-12-27 | ||
| Adtralza | Tralokinumab | 2021-06-17 | ||
| Desonate | Desonide | 2006-10-20 | 2025-2027 | |
| Dovonex | Calcipotriene | 1993-12-29 | 2026-2039 | |
| Enstilar | Betamethasone, Calcipotriene | 2015-10-16 | 2027-2039 | |
| Finacea | Azelaic acid | 2002-12-24 | 2024-2029 | |
| Innohep | Tinzaparin | 2000-07-14 | ||
| Kyntheum | Brodalumab | 2017-07-17 | ||
| Picato | Ingenol mebutate | 2012-01-23 | 2026-2033 | |
| Pindac | Pinacidil | 1989-12-28 | ||
| Protopic | Tacrolimus | 2000-12-08 | 2024-2028 |
1
2
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use